Vous êtes ici

XPhyto Therapeutics Corp.

Liste d'échange: 
CSE
Statut: 
Active
Industrie: 
Life Sciences
Symbole: 
XPHY
Indice CSE: 
Devise: 

XPhyto Therapeutics Corp. (“XPhyto”) is a diversified bioscience company with strategic assets and investments in the field of rapid pathogen screening systems and next generation drug delivery, as well as medical cannabis opportunities focused on emerging European markets. Through its 100% owned subsidiaries and exclusive development and commercialization agreements, XPhyto is pursuing clinical programs for the transdermal and dissolvable oral delivery of conventional and cannabis based therapeutics for neurological applications, as well as rapid dissolvable oral biosensor and lateral flow assay-based screening tests for dental health applications and high-risk pandemic threats such as COVID-19, H1N1 (swine flu) and H5N1 (avian flu).

Vous êtes ici

XPhyto Therapeutics Corp. (XPHY)

SEDAR Information

Information d'entreprise

Addresse
Suite 270 - 1820 Fir Street
Vancouver, BC V6J 3B1
Canada
Téléphone
780-818-6422
Courriel
info@xphyto.com
Date d’inscription à la cote
Mercredi, juillet 31, 2019
Agent de transfert
Computershare Investor Services Inc.

Advertisement

Publicité

Capitalisation

Capitalisation: 
60,617,445
Réservé à l'émission: 
21,847,557

Bulletins

30/07/2019

2019-0724 – Nouvelle Inscription - XPhyto Therapeutics Corp. (XPHY)

le 30 juillet/July 2019

The common shares of XPhyto Therapeutics Corp. have been approved for listing on the CSE.

Listing and disclosure documents will be available at www.thecse.com on the trading date.

Advertisement

Publicité

Latest CSE News

Évènements à venir

2020-10-20-TT-Website.png

Tech Tuesdays

Mardi, octobre 20, 2020 -
16:15 - 17:00
2020-10-21-Cannabis-and-Tech_Website.jpg

Cannabis + Technology

Mercredi, octobre 21, 2020 - 09:30 - Jeudi, octobre 22, 2020 - 19:00
2020-09-30-The-Psychedelics-Renaissance_Website_1.png

The Psychedelics Renaissance

Mercredi, octobre 21, 2020 -
13:00 - 15:00